Gastroenterostomy and Vagotomy for Chronic Duodenal Ulcer
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Association Between Gastric Myoelectric Activity Disturbances and Dyspeptic T Symptoms in Gastrointestinal Cancer Patients ⁎ Aneta L
Advances in Medical Sciences 64 (2019) 44–53 Contents lists available at ScienceDirect Advances in Medical Sciences journal homepage: www.elsevier.com/locate/advms Original research article Association between gastric myoelectric activity disturbances and dyspeptic T symptoms in gastrointestinal cancer patients ⁎ Aneta L. Zygulskaa, , Agata Furgalab, Krzysztof Krzemienieckia,c,1, Beata Wlodarczykb, Piotr Thorb a Department of Oncology, University Hospital in Cracow, Cracow, Poland b Department of Pathophysiology, Jagiellonian University Medical College, Cracow, Poland c Department of Oncology, Jagiellonian University Medical College, Cracow, Poland ARTICLE INFO ABSTRACT Keywords: Purpose: Dyspeptic symptoms present a severe problem in gastrointestinal (GI) cancer patients. The aim of the Gastrointestinal carcinoma study was to analyze an association between gastric myoelectric activity changes and dyspeptic symptoms in Gastric motility gastrointestinal cancer patients. Gastric myoelectric activity Material and Methods: The study included 80 patients (37 men and 43 women, mean age 61.2 ± 7.8 years) Electrogastrography diagnosed with GI tract malignancies: colon (group A), rectal (group B) and gastric cancers (group C). Gastric Dyspeptic symptoms myoelectric activity in a preprandial and postprandial state was determined by means of a 4-channel electro- gastrography. Autonomic nervous system was studied based on heart rate variability analysis. The results were compared with the data from healthy asymptomatic controls. Results: In a fasted state, GI cancer patients presented with lesser percentages of normogastria time (A:44.23 vs. B:46.5 vs. C:47.10 vs. Control:78.2%) and average percentage slow wave coupling (ACSWC) (A:47.1 vs. B:50.8 vs. C:47.2 vs. Control:74.9%), and with higher values of dominant power (A:12.8 vs. -
About Your Gastrectomy Surgery
Patient & Caregiver Education About Your Gastrectomy Surgery About Your Surgery .................................................................................................................3 Before Your Surgery .................................................................................................................5 Preparing for Your Surgery ............................................................................................................6 Common Medications Containing Aspirin and Other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) ............................................................... 14 Herbal Remedies and Cancer Treatment ................................................................................ 19 Information for Family and Friends for the Day of Surgery ............................................22 After Your Surgery .................................................................................................................27 What to Expect ............................................................................................................................... 28 How to Use Your Incentive Spirometer .................................................................................. 32 Patient-Controlled Analgesia (PCA) ....................................................................................... 35 Eating After Your Gastrectomy ..................................................................................................37 Resources ................................................................................................................................53 -
Laparoscopic Truncal Vagotomy and Gatrojejunostomy for Pyloric Stenosis
ORIGINAL ARTICLE pISSN 2234-778X •eISSN 2234-5248 J Minim Invasive Surg 2015;18(2):48-52 Journal of Minimally Invasive Surgery Laparoscopic Truncal Vagotomy and Gatrojejunostomy for Pyloric Stenosis Jung-Wook Suh, M.D.1, Ye Seob Jee, M.D., Ph.D.1,2 Department of Surgery, 1Dankook University Hospital, 2Dankook University School of Medicine, Cheonan, Korea Purpose: Peptic ulcer disease (PUD) remains one of the most prevalent gastrointestinal diseases and Received January 27, 2015 an important target for surgical treatment. Laparoscopy applies to most surgical procedures; however Revised 1st March 9, 2015 its use in elective peptic ulcer surgery, particularly in cases of pyloric stenosis, has not been popular. 2nd March 28, 2015 The aim of this study was to describe the role of laparoscopic surgery and an easily performed Accepted April 20, 2015 procedure for pyloric stenosis. We accordingly performed laparoscopic truncal vagotomy with gastrojejunostomy in 10 consecutive patients with pyloric stenosis. Corresponding author Ye Seob Jee Methods: Data were collected prospectively from all patients who underwent laparoscopic truncal Department of Surgery, Dankook vagotomy with gastrojejunostomy from August 2009 to May 2014 and reviewed retrospectively. University Hospital, Dankook Results: A total of 10 patients underwent laparoscopic trucal vagotomy with gastrojejunostomy for University School of Medicine, 119, peptic ulcer obstruction from August 2009 to May 2014 in ○○ university hospital. The mean age was Dandae-ro, Dongnam-gu, Cheonan 62.6 (±16.4) years old and mean BMI was 19.3 (±2.5) kg/m2. There were no conversions to open 330-714, Korea surgery and no occurrence of intra-operative complications. -
Thoracoscopic Truncal Vagotomy Versus Surgical Revision of the Gastrojejunal Anastomosis for Recalcitrant Marginal Ulcers
Surgical Endoscopy (2019) 33:607–611 and Other Interventional Techniques https://doi.org/10.1007/s00464-018-6386-7 2018 SAGES ORAL DYNAMIC Thoracoscopic truncal vagotomy versus surgical revision of the gastrojejunal anastomosis for recalcitrant marginal ulcers Alicia Bonanno1 · Brandon Tieu2 · Elizabeth Dewey1 · Farah Husain3 Received: 1 May 2018 / Accepted: 10 August 2018 / Published online: 21 August 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract Introduction Marginal ulcer is a common complication following Roux-en-Y gastric bypass with incidence rates between 1 and 16%. Most marginal ulcers resolve with medical management and lifestyle changes, but in the rare case of a non-healing marginal ulcer there are few treatment options. Revision of the gastrojejunal (GJ) anastomosis carries significant morbidity with complication rates ranging from 10 to 50%. Thoracoscopic truncal vagotomy (TTV) may be a safer alternative with decreased operative times. The purpose of this study is to evaluate the safety and effectiveness of TTV in comparison to GJ revision for treatment of recalcitrant marginal ulcers. Methods A retrospective chart review of patients who required surgical intervention for non-healing marginal ulcers was performed from 1 September 2012 to 1 September 2017. All underwent medical therapy along with lifestyle changes prior to intervention and had preoperative EGD that demonstrated a recalcitrant marginal ulcer. Revision of the GJ anastomosis or TTV was performed. Data collected included operative time, ulcer recurrence, morbidity rate, and mortality rate. Results Twenty patients were identified who underwent either GJ revision (n = 13) or TTV (n = 7). There were no 30-day mortalities in either group. -
Effects of Sleeve Gastrectomy Plus Trunk Vagotomy Compared with Sleeve Gastrectomy on Glucose Metabolism in Diabetic Rats
Submit a Manuscript: http://www.f6publishing.com World J Gastroenterol 2017 May 14; 23(18): 3269-3278 DOI: 10.3748/wjg.v23.i18.3269 ISSN 1007-9327 (print) ISSN 2219-2840 (online) ORIGINAL ARTICLE Basic Study Effects of sleeve gastrectomy plus trunk vagotomy compared with sleeve gastrectomy on glucose metabolism in diabetic rats Teng Liu, Ming-Wei Zhong, Yi Liu, Xin Huang, Yu-Gang Cheng, Ke-Xin Wang, Shao-Zhuang Liu, San-Yuan Hu Teng Liu, Ming-Wei Zhong, Xin Huang, Yu-Gang Cheng, reviewers. It is distributed in accordance with the Creative Ke-Xin Wang, Shao-Zhuang Liu, San-Yuan Hu, Department Commons Attribution Non Commercial (CC BY-NC 4.0) license, of General Surgery, Qilu Hospital of Shandong University, Jinan which permits others to distribute, remix, adapt, build upon this 250012, Shandong Province, China work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and Yi Liu, Health and Family Planning Commission of Shandong the use is non-commercial. See: http://creativecommons.org/ Provincial Medical Guidance Center, Jinan 250012, Shandong licenses/by-nc/4.0/ Province, China Manuscript source: Unsolicited manuscript Author contributions: Liu T, Liu SZ and Hu SY designed the study and wrote the manuscript; Liu T and Zhong MW instructed Correspondence to: San-Yuan Hu, Professor, Department of on the whole study and prepared the figures; Liu Y and Wang KX General Surgery, Qilu Hospital of Shandong University, No. 107, collected and analyzed the data; Liu T, Huang X and Cheng YG Wenhua Xi Road, Jinan 250012, Shandong Province, performed the operations and performed the observational study; China. -
A Matched Cohort Analysis of Single Anastomosis Loop Duodenal Switch Versus Roux-En-Y Gastric Bypass with 18-Month Follow-Up - Springer
A matched cohort analysis of single anastomosis loop duodenal switch versus Roux-en-Y gastric bypass with 18-month follow-up - Springer Search Submit Article Surgical Endoscopy pp 1-7 First online: 22 December 2015 A matched cohort analysis of single anastomosis loop duodenal switch versus Roux-en-Y gastric bypass with 18-month follow-up Austin Cottam, Daniel Cottam , Walter Medlin, Christina Richards, Samuel Cottam, Hinali Zaveri, Amit Surve 10.1007/s00464-015-4707-7 Copyright information Abstract Background The Roux-en-Y gastric bypass (GBP) has been considered the gold standard for many years. The loop duodenal switch (LDS) is a relatively new procedure that simplifies the complexity of the duodenal switch (BPDDS) by making it a single anastomosis procedure while at the same time giving it more intestinal absorption to reduce the rates of malnutrition associated with traditional BPDDS. This paper seeks to compare the 18-month weight loss outcomes and complications of the more standard GBP with the newer LDS in a single US center. Methods A retrospective matched cohort was analyzed on 108 patients who had either GBP (54 patients) or LDS (54 patients). Regression analysis was used to compare weight loss outcomes as measured by BMI and weight loss percentages. Complications gathered included bleeds, reoperations, diagnostic or therapeutic endoscopy (EGD), ulcers and chronic nausea. Results GBP and LDS have statistically similar weight loss at 18 months (39.6 vs 41 % weight loss, respectively). However, there were significantly more nausea complaints (26 vs 5), diagnostic endoscopies (EGD) (21 vs 3) and ulcers (6 vs 0) with the GBP than the LDS. -
Biliopancreatic Diversion with a Duodenal Switch
Obesity Surgeuy, 8, 267-282 Biliopancreatic Diversion with a Duodenal Switch Douglas S. Hess MD, FACS; Douglas W. Hess MD Wood County Hospital, Bowling Green, OH, USA Background: This paper evaluates biliopancreatic BPD without some of the associated problems. diversion combined with the duodenal switch, form- This operation is now used by us for all our ing a hybrid procedure which is a combination of bariatric patients, both in primary surgical proce- restriction and malabsorption. Methods: The evaluation is of the first 440 patients dures and reoperations. undergoing this procedure who had had no previous The difficulty of establishing an operation that bariatric surgery. The mean starting weight was has both long- and short-term success is well 183 kg, with 41% of our patients considered super known. Bariatric surgery is either restrictive or morbidly obese (BMI > 50). malabsorptive in nature, each with its own ad- Results: There was an average maximum weight loss of 80% excess weight by 24 months post- vantages, disadvantages and complications. While operation; this continued at a 70% level for 8 years. trying to find a procedure that would produce Major complications were found in almost 9% of the better long-term results and fewer failures, i.e. cases. There were two perioperative deaths, one regain of weight, we began to look at the from pulmonary embolism and one from acute Scopinaro BPD.l First of all we considered it pulmonary obstruction. There were 36 type II dia- betics, all of whom have discontinued medication only for reoperations on failed restrictive proce- following the surgery. -
Value of 48- Or 72-Hr Urine Collections in Performing the Schilling Test
VALUE OF 48- OR 72-HR URINE COLLECTIONS IN PERFORMING THE SCHILLING TEST Edward B. Silberstein Radioisotope Laboratory, Cincinnati General Hospital, Cincinnati, Ohio In 21 % of 71 consecutive, normal Schilling serum vitamin B,2 levels less than 50 pg/mI, and tests evaluated in the Radioisotope Laboratory patients with abnormal vitamin B12 absorption as of the Cincinnati General Hospital, normal 57Co measured by a whole-body counter (6—10). cyanocobalamin excretion (greater than 8% of The test was performed, as previously described a test dose of 0.5 @g)was not achieved until 48— (5), with 0.5 @gof 57Co-cyanocobalamin, 1 @@Ci/ 72 hr. it is recommended that the vitamin B,2 @Lg;however, instead of a single day's collection, adsorption test, as described by Schilling, be serial 24-hr urines were collected for 48—72 hr with altered to routinely include at least a 48-hr additional “flushing―doses of 1 mg of cyanoco urine collection. balamin given intramuscularly at the beginning of the second and third days of the test. Each individual in this study produced at least 500 ml of urine per The Schilling test remains an important diagnos 24 hr with creatinine content exceeding 15 mg/kg tic procedure in the study of patients with megalo body weight if volume was under 500 ml to prove blastic anemia and/or peripheral neuropathy. In the that a full day's collection was made (1 1) . The 72-hr original description of the vitamin B,2 absorption collection was made if there was azotemia (BUN test by Schilling ( 1) , a 24-hr urine collection was exceeding 25 mg% ) or in any patient older than obtained after the oral administration of radioactive 65 years. -
Technic VERTICAL GASTROPLASTY WITH
ABCDDV/802 ABCD Arq Bras Cir Dig Technic 2011;24(3): 242-245 VERTICAL GASTROPLASTY WITH JEJUNOILEAL BYPASS - NEW TECHNICAL PROCEDURE Gastroplastia vertical com desvio jejunoileal - novo procedimento técnico Bruno ZILBERSTEIN, Arthur Sergio da SILVEIRA-FILHO, Juliana Abbud FERREIRA, Marnay Helbo de CARVALHO, Cely BUSSONS, Henrique JOAQUIM, Fernando RAMOS From Gastromed-Instituto Zilberstein, São ABSTRACT - Introduction - Vertical gastroplasty is increasingly used in the surgical Paulo, SP, Brasil. treatment of morbid obesity, being used alone or as part of the duodenal switch surgery or even in intestinal bipartition (Santoro technique). When used alone has only a restrictive character. Method - Is proposed association of jejunoileal bypass to vertical gastroplasty, in order to give a metabolic component to the procedure and eventually empower it to medium and long term. Eight morbidly obese patients were operated after removal of adjustable gastric band or as a primary procedure associated to vertical banded gastroplasty with jejunoileal bypass laterolateral and anastomosis between the jejunum 80 cm from duodenojejunal angle and the ileum at 120 cm from ileocecal valve, by laparoscopy. Results - The patients presented themselves without complications both in trans or in the immediate postoperative period, and also in the months that followed. The evolution BMI showed a significant reduction ranging from 39.57 kg/m2 to 28 kg/m2. No patient reported diarrhea or malabsorptive disorder in HEADINGS - Sleeve gastrectomy. Jejunoileal the period. Conclusion - It can be offered a new therapeutic option, with restraining diversion. Obesity. Surgery. and metabolic aspects, in which there are no consequences as the ones founded in procedures with duodenal diversion or intestinal transit alterations. -
The Reliability and Reproducibility of the Schilling Test in Primary Malabsorptive Disease and After Partial Gastrectomy
Gut: first published as 10.1136/gut.4.1.32 on 1 March 1963. Downloaded from Gut, 1963, 4, 32 The reliability and reproducibility of the Schilling test in primary malabsorptive disease and after partial gastrectomy J. F. ADAMS AND E. JUNE CARTWRIGHT From the Western Infirmary, Glasgow EDITORIAL SYNOPSIS A study of the reproducibility and reliability of the Schilling test in patients with primary malabsorptive disease and after partial gastrectomy is reported. The value of the test was assessed by repeated tests in each patient. Consistently normal or abnormal results were obtained in only one of the seven patients with primary malabsorptive disease and in only two of the eight patients who had undergone partial gastrectomy. From these results it is concluded that the result of a single test may be of little clinical value. Assessment of the results suggests that the mean value for a series of Schilling tests may give some indication of value clinically about the capacity to absorb radioactive vitamin B12 at the time of the tests at least in patients who have undergone partial gastrectomy. The significance of the findings is discussed, particularly in relation to the aetiology of post-gastrectomy megaloblastic anaemia. http://gut.bmj.com/ Absorption tests using radioactive vitamin B12 may ml. water; two hours later 1,000 ptg. vitamin B12 was given be of considerable value in establishing a precise intramuscularly and urine was collected for the subsequent diagnosis in conditions in which anaemia results 24 hours. The radioactivity in a 450 ml. aliquot was from malabsorption. It is obviously important to measured as described by Adams and Seaton (1961) and the total urinary radioactivity expressed as a percentage appreciate the limitations of such tests. -
Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy with Hospitalization for Upper Gastrointestinal Tract Bleeding
Supplementary Online Content Ray WA, Chung CP, Murray KT, et al. Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding. JAMA. doi:10.1001/jama.2018.17242 eAppendix. PPI Co-therapy and Anticoagulant-Related UGI Bleeds This supplementary material has been provided by the authors to give readers additional information about their work. Downloaded From: https://jamanetwork.com/ on 10/02/2021 Appendix: PPI Co-therapy and Anticoagulant-Related UGI Bleeds Table 1A Exclusions: end-stage renal disease Diagnosis or procedure code for dialysis or end-stage renal disease outside of the hospital 28521 – anemia in ckd 5855 – Stage V , ckd 5856 – end stage renal disease V451 – Renal dialysis status V560 – Extracorporeal dialysis V561 – fitting & adjustment of extracorporeal dialysis catheter 99673 – complications due to renal dialysis CPT-4 Procedure Codes 36825 arteriovenous fistula autogenous gr 36830 creation of arteriovenous fistula; 36831 thrombectomy, arteriovenous fistula without revision, autogenous or 36832 revision of an arteriovenous fistula, with or without thrombectomy, 36833 revision, arteriovenous fistula; with thrombectomy, autogenous or nonaut 36834 plastic repair of arteriovenous aneurysm (separate procedure) 36835 insertion of thomas shunt 36838 distal revascularization & interval ligation, upper extremity 36840 insertion mandril 36845 anastomosis mandril 36860 cannula declotting; 36861 cannula declotting; 36870 thrombectomy, percutaneous, arteriovenous -
A New Look at Vitaminb
A new look at vitaminB 18 The Nurse Practitioner • Vol. 34, No. 11 www.tnpj.com 2.5 CONTACT HOURS 12 deficiency By Sandra M. Nettina, APRN-BC, ANP, MSN ona Abraham is a 78-year-old widow who sees you for refill of her arthritis and antihypertensive med- M ications. She recently relocated from another state to be closer to her daughter, although she lives in her own “se- nior” apartment. Through history taking, you learn that she has a long history of osteoarthritis, mild hypertension requir- ing medication for the past 5 years, and occasional gastroe- sophageal reflux. Surgical history includes appendectomy as a teenager, a ventral hernia repair after her last child was born, and right knee arthroscopy about 5 years ago. Her medications include triamterene/hydrochlorthiazide 37.5/25 mg daily, acetaminophen 650 mg (2) twice daily , cal- cium citrate 600 mg/vitamin D 400 international units twice daily, omeprazole 20 mg daily p.r.n for heartburn, and hy- drocodone/acetaminophen 5/325 mg every 6h p.r.n. for severe pain. You perform a physical exam, discuss healthy diet and physical activity, order serum electrolytes and creatinine, refill her prescriptions, and advise her to schedule a follow-up ap- pointment in 3 months for preventative screening. You are about to conclude the visit and leave the room when Mrs. Abra- ham asks if she can get a vitamin B12 shot now. You question her about her need for B12 and Mrs. Abraham states she never knew how her previous primary care provider knew she had a vitamin B12 deficiency, but monthly shots have helped boost her energy over the past year.